Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2015; 14: 44-48
Случай развития нейробластомы у ребенка с синдромом Шерешевского-Тернера
https://doi.org/10.24287/1726-1708-2015-14-4-44-48Аннотация
Список литературы
1. Goodman M, Gurney J, Smith M, Olshan A. Sympathetic nervous system tumors. In: Ries LAG, Smith M, Gurney J, Linet M, Tamra T, Young J, et al., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD; 1999: 65-72.
2. Shojaei-Brosseau T, Chompret A, Abel A, de Vathaire F, Raquin MA, Brugières L, et al. Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institute Gustave-Roussy in France. Pediatr Blood Cancer. 2004; 42(1): 99-105.
3. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998; 132(3, Pt 1): 398-400.
4. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997; 60(3): 474-85.
5. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer. 1991; 63(6): 993-9.
6. Lanzkowski P. Manual of pediatric haematology and oncology. 4th ed. Elsevier; 2005.
7. Satgé D, Moore SW, Stiller CA, Niggli FK, Pritchard-Jones K, Bown N, et al. Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature. Cancer Genet Cytogenet. 2003; 147(2): 89-98.
8. Blatt J, Olshan AF, Lee PA, Ross JL. Neuroblastoma and related tumors in Turner’s syndrome. J Pediatr. 1997; 131(5): 666-70.
9. Simon T, Spitz R, Faldum A, Hero B, Berthold F. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol. 2004; 26(12): 791-6.
10. Jones K. Smith’s recognizable patterns of human malformation. 6th ed. Philadelphia, Pa: Elsevier Saunders; 2006.
11. Choyke PL, Siegel MJ, Craft AW, Green DM, DeBaun MR. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol. 1999; 32(3): 196-200.
12. Tyler C, Edman JC. Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span. Prim Care. 2004; 31(3): 627-48.
13. Turner H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 1938; 23: 566-74.
14. Satgé D, Sasco AJ, Plantaz D, Bénard J, Vekemans MJ. Abnormal number of X chromosomes and neuroblastic tumors. J Pediatr Hematol Oncol. 2001; 23(5): 331 -2.
15. Mateos ME, Löpez-Laso E, Pérez-Navero JL. Klinefelter syndrome and neuroblastoma. Pediatr Blood Cancer. 2011; 57(4): 696.
16. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 1997; 150(1): 81-9.
Pediatric Hematology/Oncology and Immunopathology. 2015; 14: 44-48
Development of neuroblastoma in a child with Shereshevsky-Turner’s syndrome
https://doi.org/10.24287/1726-1708-2015-14-4-44-48Abstract
References
1. Goodman M, Gurney J, Smith M, Olshan A. Sympathetic nervous system tumors. In: Ries LAG, Smith M, Gurney J, Linet M, Tamra T, Young J, et al., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD; 1999: 65-72.
2. Shojaei-Brosseau T, Chompret A, Abel A, de Vathaire F, Raquin MA, Brugières L, et al. Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institute Gustave-Roussy in France. Pediatr Blood Cancer. 2004; 42(1): 99-105.
3. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998; 132(3, Pt 1): 398-400.
4. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997; 60(3): 474-85.
5. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer. 1991; 63(6): 993-9.
6. Lanzkowski P. Manual of pediatric haematology and oncology. 4th ed. Elsevier; 2005.
7. Satgé D, Moore SW, Stiller CA, Niggli FK, Pritchard-Jones K, Bown N, et al. Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature. Cancer Genet Cytogenet. 2003; 147(2): 89-98.
8. Blatt J, Olshan AF, Lee PA, Ross JL. Neuroblastoma and related tumors in Turner’s syndrome. J Pediatr. 1997; 131(5): 666-70.
9. Simon T, Spitz R, Faldum A, Hero B, Berthold F. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol. 2004; 26(12): 791-6.
10. Jones K. Smith’s recognizable patterns of human malformation. 6th ed. Philadelphia, Pa: Elsevier Saunders; 2006.
11. Choyke PL, Siegel MJ, Craft AW, Green DM, DeBaun MR. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol. 1999; 32(3): 196-200.
12. Tyler C, Edman JC. Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span. Prim Care. 2004; 31(3): 627-48.
13. Turner H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 1938; 23: 566-74.
14. Satgé D, Sasco AJ, Plantaz D, Bénard J, Vekemans MJ. Abnormal number of X chromosomes and neuroblastic tumors. J Pediatr Hematol Oncol. 2001; 23(5): 331 -2.
15. Mateos ME, Löpez-Laso E, Pérez-Navero JL. Klinefelter syndrome and neuroblastoma. Pediatr Blood Cancer. 2011; 57(4): 696.
16. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 1997; 150(1): 81-9.
